Tri Locum Partners’s Inspire Medical Systems INSP Stock Holding History

Tri Locum Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-149,244	Closed	-$19.4M	–	22
2025 Q2	$19.4M	Buy	149,244 +70,432	+89%	+$10.2M	5.88%	8
2025 Q1	$12.6M	Sell	78,812 -71,976	-48%	-$13M	6.44%	5
2024 Q4	$28M	Sell	150,788 -641	-0.4%	-$124K	5.79%	5
2024 Q3	$32M	Buy	151,429 +18,153	+14%	+$3.15M	7.66%	6
2024 Q2	$17.8M	Buy	133,276 +109,710	+466%	+$20.8M	4.51%	11
2024 Q1	$5.06M	Buy	+23,566	New	+$4.62M	1.76%	21
2023 Q2	–	Sell	-17,523	Closed	-$4.1M	–	72
2023 Q1	$4.1M	Buy	+17,523	New	+$4.43M	1.25%	25
2022 Q4	–	Sell	-23,412	Closed	-$4.15M	–	83
2022 Q3	$4.15M	Sell	23,412 -8,293	-26%	-$1.67M	1.14%	30
2022 Q2	$5.79M	Buy	+31,705	New	+$6.32M	2.37%	17

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tri Locum Partners's INSP Position: Q3 2025 in Review

Tri Locum Partners sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 149,244 shares — an estimated $19.4M sold.

Tri Locum Partners first reported a position in INSP in Q2 2022 and held it in 9 quarters. The position peaked at $32M in Q3 2024. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

Tri Locum Partners reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
Tri Locum Partners sold 149,244 Inspire Medical Systems shares in Q3 2025, an estimated $19.4M.
Tri Locum Partners first reported a position in Inspire Medical Systems in Q2 2022 and held it in 9 quarters.
Tri Locum Partners's Inspire Medical Systems position peaked at $32M in Q3 2024.
325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Tri Locum Partners's 13F filing for Q3 2025, filed 14 Nov 2025.